Table 3.
Follow-up AOM medication switches and restarts
| First-visit AOM | First-visit prescriptions (n) | AOM switch/restart prescriptions (n) | ||||
|---|---|---|---|---|---|---|
| Orlistat | PHEN/TOP | Liraglutide | Lorcaserin | Nal/Bup | ||
| Liraglutide | 40 | 0 | 8 | 3 | 1 | 3 |
| Lorcaserin | 9 | 0 | 1 | 0 | 0 | 0 |
| Orlistat | 19 | 1 | 2 | 0 | 0 | 0 |
| PHEN/TOP | 81 | 1 | 1 | 10 | 5 | 0 |
Abbreviations: AOM, antiobesity medication;; Nal/Bup, naltrexone/bupropion; PHEN/TOP, phentermine/topiramate ER.
AOM switch/restart prescriptions: the number of times a patient for each specific first-visit AOM switched to different AOM or restarted initial AOM were tabulated. Patients who stopped initial AOM at WMC visit or switched to different AOM then restarted initial AOM were tabulated as restarting initial AOM.